Reports
Global Immunomodulators Market: By Product: Immunosuppressants, Immunostimulants; By Application: Oncology, Respiratory, HIV, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments
Global Immunomodulators Market Outlook
The global immunomodulators market attained a value of about USD 175 billion in 2020. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 5.8% to reach nearly USD 245 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to Contribute Significant Share in the Global Immunomodulators Industry
North America is a significant market for the global immunomodulatory industry because of the growing geriatric population in this region. Due to the surging incidence of chronic diseases like sclerosis, Crohn’s disease, ulcerative colitis in the United States, demand from end-users for immunomodulator-based treatment and the high therapy cost associated with the treatment of sclerosis are anticipated to drive revenue growth in this segment. Further, awareness among the masses and government initiatives are also boosting the immunomodulator industry. Europe, on the other hand, is expected to witness substantial growth backed by the increasing sales of immunosuppressant products in the region.
Impact of COVID-19
COVID-19 has shown its footprint across the globe, severely affecting many economies and industries due to lockdowns and several restrictions. However, coronavirus has positively affected the immunomodulator industry, owing to rise in the sales of products with respect to the emergency. Various pharmaceutical companies are trying to balance demand and supply to keep their sales flow smooth. These pharmaceutical companies are now trying to invest more in quality control, strengthen their research and development departments, and magnify supply chain management, which is expected to boost the market growth over the forecast period.
Immunomodulators: Market Segmentation
Immunomodulators are substances that are used to regulate or normalise the immunity system. It supports immune function by modifying, generally in a healthy way, the immune system’s response to a threat. They are directed to enhance the immune response against infectious diseases, tumours, primary or secondary immunodeficiency, and alterations in antibody transfer, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major types of immunomodulators on the basis of product are:
- Immunosuppressants
- Antibodies
- Calcineurin Inhibitors
- Glucocorticoid
- Antimetabolites
- Others
- Immunostimulants
- Vaccines
- Antibodies
- Others
The market can be broadly categorised on the basis of its applications into:
- Oncology
- Respiratory
- HIV
- Others
The EMR report looks into the regional markets of immunomodulators like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increase in the Number of Chronic Diseases is Driving the Immunomodulator Industry
The key contributory factor in the growth of the global immunomodulators industry is the increasing incidence of chronic diseases, including asthma, allergic conditions, cancer, and multiple sclerosis. Further, some of the factors contributing to the growth of the immunomodulator industry include the prevailing cases of organ transplantation, increasing adoption of an early immunomodulator therapy for the Crohn’s disease treatment, rising awareness about inflammatory bowel diseases, growing autoimmune diseases, and increasing development of drug resistance, which is resulting in the rise of immunomodulators usage.
However, the market growth may hinder due to the presence of stringent regulatory approval procedures, along with the high cost of the therapy and the immunomodulator products. Further, adverse effects of immunomodulatory drugs, such as pain, inflammation, epilepsy, are likely to restrain the market growth during the forecast period.
Key Industry Players in the Global Immunomodulators Market
The report presents a detailed analysis of the following key players in the global immunomodulators market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffmann-La Roche Ltd.
- Amgen, Inc.
- Abbott Laboratories
- Novartis AG
- Biogen Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, Region |
| Breakup by Product | Immunosuppressants, Immunostimulants |
| Breakup by Application | Oncology, Respiratory, HIV, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Novartis AG, Biogen Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Immunomodulators Market Analysis
8.1 Key Industry Highlights
8.2 Global Immunomodulators Historical Market (2018-2022)
8.3 Global Immunomodulators Market Forecast (2023-2028)
8.4 Global Immunomodulators Market by Product
8.4.1 Immunosuppressants
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.1.4 Breakup by Products
8.4.1.4.1 Antibodies
8.4.1.4.1.1 Market Share
8.4.1.4.1.2 Historical Trend (2018-2022)
8.4.1.4.1.3 Forecast Trend (2023-2028)
8.4.1.4.2 Calcineurin Inhibitors
8.4.1.4.2.1 Market Share
8.4.1.4.2.2 Historical Trend (2018-2022)
8.4.1.4.2.3 Forecast Trend (2023-2028)
8.4.1.4.3 Glucocorticoid
8.4.1.4.3.1 Market Share
8.4.1.4.3.2 Historical Trend (2018-2022)
8.4.1.4.3.3 Forecast Trend (2023-2028)
8.4.1.4.4 Antimetabolites
8.4.1.4.4.1 Market Share
8.4.1.4.4.2 Historical Trend (2018-2022)
8.4.1.4.4.3 Forecast Trend (2023-2028)
8.4.1.4.5 Others
8.4.2 Immunostimulants
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.2.4 Breakup by Product
8.4.2.4.1 Vaccines
8.4.2.4.1.1 Market Share
8.4.2.4.1.2 Historical Trend (2018-2022)
8.4.2.4.1.3 Forecast Trend (2023-2028)
8.4.2.4.2 Antibodies
8.4.2.4.2.1 Market Share
8.4.2.4.2.2 Historical Trend (2018-2022)
8.4.2.4.2.3 Forecast Trend (2023-2028)
8.4.2.4.3 Others
8.5 Global Immunomodulators Market by Application
8.5.1 Oncology
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Respiratory
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 HIV
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Immunomodulators Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2022)
8.6.5.3 Forecast Trend (2023-2028)
9 North America Immunomodulators Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Immunomodulators Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Immunomodulators Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Immunomodulators Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Immunomodulators Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 F. Hoffmann-La Roche Ltd.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Amgen, Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Abbott Laboratories
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Novartis AG
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Biogen Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
Additional Customisations Available
1 Manufacturing Process
1.1 Overview
1.2 Detailed Process Flow
1.3 Operation Involved
2 Project Requirement and Cost Analysis
2.1 Land, Location and Site Development
2.2 Construction
2.3 Plant Machinery
2.4 Cost of Raw Material
2.5 Packaging
2.6 Transportation
2.7 Utilities
2.8 Manpower
2.9 Other Capital Investment
List of Key Figures and Tables
1. Global Immunomodulators Market: Key Industry Highlights, 2018 and 2028
2. Global Immunomodulators Historical Market: Breakup by Product (USD Million), 2018-2022
3. Global Immunomodulators Market Forecast: Breakup by Product (USD Million), 2023-2028
4. Global Immunomodulators Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Immunomodulators Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Immunomodulators Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global Immunomodulators Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America Immunomodulators Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America Immunomodulators Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe Immunomodulators Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe Immunomodulators Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific Immunomodulators Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific Immunomodulators Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America Immunomodulators Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America Immunomodulators Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa Immunomodulators Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa Immunomodulators Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Global Immunomodulators Market Structure
Key Questions Answered in the Report
In 2020, the global immunomodulators market attained a value of nearly USD 175 billion.
The market is projected to grow at a CAGR of 5.8% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 245 billion by 2026.
The market is being driven by the prevailing cases of organ transplantation that boosts the demand for immunomodulator drugs, growing geriatric population, and rising incidence of chronic diseases.
The key industry trend that is influencing the market growth includes the combination of antigen and immunomodulators as it targets the pathways that treat multiple diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The different products of immunomodulators available in the industry are immunosuppressants and immunostimulants.
The major applications of immunomodulators are oncology, respiratory, and HIV, among others.
The major players in the industry are F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Novartis AG, and Biogen Inc., among others.
Analyst Review
The global immunomodulators market attained an approximate value of USD 175 billion in 2020, driven by the rising prevalence of awareness among the masses regarding immunomodulators. Aided by the rising chronic diseases, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 5.8%. The market is projected to reach nearly USD 245 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the immunomodulators industry can be segmented into immunosuppressants and immunostimulants. On the basis of application, the market is categorised into oncology, respiratory, and HIV, among others. The major regional markets for immunomodulators are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Novartis AG, and Biogen Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER